| Filed On | Filing |
|---|---|
| 01 Oct 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 01 Oct 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 12 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 | REGISTRATION STATEMENT |
| 12 Aug 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 29 Jul 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 21 Jul 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 17 Jul 2026 |
Form 4: Warshavsky Ori, Chief Operating Officer - US
Granted 46,000 Stock option (right to buy) ($205K) |
| 17 Jul 2026 |
Form 4: Missulawin Jonathan, Chief Financial Officer
Granted 49,000 Stock option (right to buy) ($219K) |
| 17 Jul 2026 |
Form 4: Hazan Dalit Fellous, Deputy CEO, EVP, RD, CRA
Granted 75,000 Stock option (right to buy) ($335K) |
| 17 Jul 2026 |
Form 4: Barenholz Yechezkel, Director
Granted 9,132 Stock option (right to buy) ($40.7K) |
| 17 Jul 2026 |
Form 4: Stein Robert Benjamin, Director
Granted 9,132 Stock option (right to buy) ($40.7K) |
| 17 Jul 2026 |
Form 4: Dror-Darwish Nir, Director
Granted 9,132 Stock option (right to buy) ($40.7K) |
| 17 Jul 2026 |
Form 4: BenAmram Joseph, Director
Granted 9,132 Stock option (right to buy) ($40.7K) |
| 17 Jul 2026 |
Form 4: Krinsky Itzhak, Director
Granted 9,132 Stock option (right to buy) ($40.7K) |
| 17 Jul 2026 |
Form 4: Story Brooke, Director
Granted 9,132 Stock option (right to buy) ($40.7K) |
| 17 Jul 2026 |
Form 4: Akselbrad Dikla Czaczkes, Director
Granted 149,000 Stock option (right to buy) ($665K) |
| 15 Jul 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
Loading...